参考文献/References:
[1]史仲珣,秦铁军,徐泽锋,等.平均红细胞体积≤100f1是骨髓原始细胞＜5%骨髓增生异常综合征患者的独立预后因素[J].中华血液学杂志,2020,41(1):28-33.[2]Buechter M,Manka P,Theysohn JM,et al.Spleen stiffness is positively correlated with HVPG and decreasessignificantly after TIPS implantation[J].Dig Liver Dis,2018,50(1):54-60.[3]李琼,刘闪闪,徐丽红,等.肝、脾硬度预测食管胃底静脉曲张及出血风险[J].中国医学影像技术,2018,34(4):563-567.[4]Iurlo A,Cattaneo D,Giunta M,et al.Reply To: Assessment of Liver and Spleen Stiffness in Patients With Myelofibrosis Using FibroScan and Shear Wave Elastography[J].Ultrasound Q,2016,32(3):317.[5]武明莉,李琳.染色体异常核型八例[J].中华医学遗传学杂志,2020,37(8):906.[6]Choi SM,O’Malley DP.Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms[J].Ann Diagn Pathol,2017,37(1):67-74.[7]Tag-Adeen M,Alsenbesy M,Ghweil AA,et al.Liver stiffness measurement and spleen diameter as predictors for the presence of esophageal varices in chronic hepatitis C patients[J].Medicine (Baltimore),2017,96(46):e8621.[8]Sharma P,Kirnake V,Tyagi P,et al.Spleen Stiffness in Patients With Cirrhosis in Predicting Esophageal Varices[J].Am J Gastroenterol,2013,108(7):1101-1107.[9]林欣,尚国臣,齐翠花,等.利用瞬时弹性成像技术对肝脏、脾脏硬度的测定及其与肝硬化食管静脉曲张程度的关系[J].中华消化杂志,2018,38(2):129-131.[10]Ravaioli F,Marasco G,Reggiani MB,et al.Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens[J].Digestive & Liver Disease,2017,49(1):e40-e41.[11]展世宏,成芳芳,缪洁,等.先天性白血病临床特征分析[J].临床儿科杂志,2019,37(3):170-172.[12]刘为易,全日城,赵攀,等.骨髓增生异常综合征患者基因突变情况分析[J].白血病·淋巴瘤,2018,27(8):449-452.[13]杨隽,蔡宇,姜杰玲,等.异基因造血干细胞移植治疗高龄髓系肿瘤30例临床分析[J].中华血液学杂志,2018,39(8):629-633.[14]叶芳,马东升,王洁,等.骨髓增生异常综合征转化为急性髓系白血病患者的临床研究[J].中国实验血液学杂志,2018,26(1):202-207.[15]Wang J,Wang Q,Zhang H,et al.Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation[J].Transplant Cell Ther,2021,27(8):666.e1-666.e9.[16]Yu Y,Zhang TT,Wang QR,et al.Counting bone marrow blasts as a percentage of nonerythroid cells improves the prognostic evaluation of MDS with erythroid predominance[J].American Journal of Hematology,2017,92(4):e55-e57.[17]Chan LSA,Gu LC,Leitch HA,et al.Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload[J].Hematology,2021,26(1):88-95.[18]Zuanelli Brambilla C,Lobaugh SM,Ruiz JD,et al.Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy[J].Transplant Cell Ther,2021,27(9):771.e1-771.e10.[19]Fang H,Yabe M,Zhang X,et al.Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases[J].Mod Pathol,2021,34(6):1143-1152.[20]刘秋艳,王燕,龙珍珠玛,等.骨髓增生异常综合征转化为急性白血病的高危因素分析[J].临床血液学杂志,2017,30(7):524-526,531.[21]严雪芬,韦菊英,王敬瀚,等.298例骨髓增生异常综合征患者染色体核型与临床预后分析[J].中华血液学杂志,2015,36(4):297-301.[22]钱瑾,夏珺,谢新,等.伴21号染色体核型异常的骨髓增生异常综合征患者的临床特征[J].中国实验血液学杂志,2021,29(5):1528-1532.[23]吕晓东,李扬威,郭珍,等.骨髓增生异常综合征基因突变特征及突变负荷相关临床分析[J].中华医学杂志,2020,100(12):933-937. [24]Wu A,Gao P,Wu N,et al.Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes[J].BMC Cancer,2021,21(1):546.